Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer

Fig. 2

Influence of tumor pathology (a), EPO concentration (b) and VEGF concentration (c) on overall survival in a group of 148 patients with non-small cell lung cancer treated with curative radio-chemotherapy or radiotherapy. The differences in overall survival are highly significant (p = 0.005; p = 0.008; p = 0.006 in groups a, b, c respectively). Median EPO and VEGF concentration was selected as a cut-off

Back to article page